Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
gemcitabine (gemzar) (1 trial)
imatinib (gleevec) (1 trial)
Mesothelioma (Phase 2)
Trials (1 total)
Trial APIs (2 total)